TLX 1.54% $20.44 telix pharmaceuticals limited

Ann: Telix Q2 2024 Revenue/Business Highlights, Guidance Upgrade, page-25

  1. 147 Posts.
    lightbulb Created with Sketch. 47
    Stunning

    Stellar Growth

    Monopoly

    Imminent Release of New Products

    Continued Flow of Innovative Products

    Targeting Products for ALL of the Human Body

    Doors opening in new Markets Shortly

    Cash Flow Positive

    CR Not Required

    Advancing Globally

    One Stop Company

    Substantial Company Footprint

    More... read before this Post & NO Doubt Onwards...

 
watchlist Created with Sketch. Add TLX (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.